Definition
Chronic liver disease (CLD) refers to a spectrum of progressive conditions that cause longterm damage to the liver. Unlike acute liver injury, which may resolve, CLD persists for months or years, often leading to fibrosis, cirrhosis, and sometimes liver failure.
Common forms include:
- Viral hepatitis (HBV, HCV)
- Alcoholrelated liver disease
- Nonalcoholic fatty liver disease (NAFLD) and its aggressive form, nonalcoholic steatohepatitis (NASH)
- Autoimmune hepatitis
- Biliary diseases such as primary biliary cholangitis and primary sclerosing cholangitis
- Genetic disorders like Wilsons disease and hemochromatosis
Major Causes and Risk Factors
The development of CLD usually involves a combination of lifestyle, metabolic, infectious, and genetic factors.
- Alcohol consumption: Chronic heavy drinking damages hepatocytes and promotes fibrosis.
- Metabolic syndrome: Obesity, type 2 diabetes, dyslipidemia, and hypertension increase the risk of NAFLD/NASH.
- Viral infections: Persistent hepatitis B or C infection leads to ongoing inflammation.
- Autoimmune activity: The bodys immune system attacks liver tissue in autoimmune hepatitis.
- Genetic conditions: Mutations affecting copper (Wilsons) or iron (hemochromatosis) metabolism cause toxic buildup.
- Medication and toxins: Longterm use of certain drugs (e.g., methotrexate) or exposure to industrial chemicals can be hepatotoxic.
Symptoms and Signs
Early CLD may be asymptomatic. When signs appear, they often reflect reduced liver function or portal hypertension.
- Fatigue and weakness
- Rightupperquadrant discomfort or dull pain
- Jaundice (yellowing of skin and eyes)
- Pruritus (itching)
- Dark urine and pale stools
- Edema of the ankles and abdomen (ascites)
- Spiderlike vascular lesions on the skin
- Enlarged spleen
Complications such as hepatic encephalopathy, variceal bleeding, or liver cancer may develop in advanced disease.
Diagnosis
Accurate diagnosis combines clinical evaluation, laboratory tests, imaging, and sometimes histology.
| Test | What it Evaluates |
|---|---|
| Blood chemistry (ALT, AST, ALP, GGT, bilirubin) | Hepatocellular injury and cholestasis |
| Serology for viral hepatitis | HBV, HCV infection status |
| Autoantibody panels | Autoimmune hepatitis (ANA, SMA, LKM1) |
| Iron studies, ceruloplasmin | Hemochromatosis, Wilsons disease |
| Ultrasound, CT, MRI | Structural changes, nodules, portal hypertension |
| Transient elastography (FibroScan) | Noninvasive assessment of liver stiffness/fibrosis |
| Liver biopsy | Definitive histologic diagnosis when noninvasive methods are inconclusive |
Management and Treatment Options
Treatment is tailored to the underlying cause and the stage of disease.
General measures
- Abstinence from alcohol
- Weight loss (710% of body weight) for NAFLD/NASH
- Control of diabetes, hypertension, and dyslipidemia
- Vaccination against hepatitis A and B
Causespecific therapies
- Viral hepatitis: Antiviral agents (e.g., entecavir, tenofovir for HBV; directacting antivirals for HCV)
- Autoimmune hepatitis: Corticosteroids and azathioprine
- Wilsons disease: Chelating agents (penicillamine, trientine) or zinc therapy
- Hemochromatosis: Regular phlebotomy
Complication management
- Diuretics and paracentesis for ascites
- Betablockers or endoscopic band ligation for variceal bleeding
- Lactulose and rifaximin for hepatic encephalopathy
- Surveillance imaging for hepatocellular carcinoma every 6 months
Liver transplantation
Considered for endstage cirrhosis, refractory complications, or selected liver cancers. A multidisciplinary team evaluates candidacy based on MELD score, comorbidities, and psychosocial factors.
Prevention and Lifestyle Recommendations
Preventing chronic liver disease is largely about modifying risk factors before irreversible damage occurs.
- Limit alcohol intake: no more than 14 standard drinks per week for men and 7 for women.
- Maintain a balanced diet rich in fruits, vegetables, whole grains, and lean protein.
- Engage in regular physical activity (150minutes of moderate exercise per week).
- Get screened for hepatitis B and C if you belong to a highrisk group; seek treatment promptly.
- Practice safe sex and avoid sharing needles to reduce viral transmission.
- Use medications as directed; discuss any longterm drug use with a physician.
Further Reading and Support
Reliable information and patient support are essential for managing chronic liver disease.
